MedPath

KIM IVANA K

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

Phase 1
Conditions
Exudative Retinal Detachment and Uveal Melanoma
Interventions
First Posted Date
2019-09-10
Last Posted Date
2021-07-29
Lead Sponsor
Ivana K. Kim
Target Recruit Count
20
Registration Number
NCT04082962
Locations
🇺🇸

i. Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath